Placental lesions attributed to shallow implantation, excess extravillous trophoblast and decidual hypoxia: Correlation with maternal vascular malperfusion and related obstetric conditions
Placenta · 2023
DOI: 10.1016/j.placenta.2023.05.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2023. Verfasst von Adam C Lechner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States; University of Missouri, Columbia, MO, United States. Hauptthemen laut MEDLINE: Pre-Eclampsia, Hypertension, Pregnancy-Induced. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Maternal vascular malperfusion (MVM) is one of four main patterns of placental injury defined by the Amsterdam consensus statement and is associated with adverse fetal and maternal outcomes. Laminar decidual necrosis (DLN), extravillous trophoblast islands (ETIs), placental septa (PS), and basal plate multinucleate implantation-type trophoblasts (MNTs) are lesions attributed to decidual hypoxia, excess trophoblast, and shallow implantation, but are not included in the current MVM diagnostic criteria. We aimed to investigate the relationship between these lesions and MVM. METHODS: A case-control model was used to evaluate for DLN, ETIs, PS, and MNTs. Placentas with MVM on pathologic examination (defined as ≥2 related lesions) constituted the case group, and maternal age- and GPA-status-matched placentas with less than 2 lesions constituted the control group. MVM-related obstetric morbidities were recorded, including hypertension, preeclampsia, and diabetes. These were correlated with the lesions of interest. RESULTS: 200 placentas were reviewed: 100 MVM cases and 100 controls. MNTs and PS showed significant enrichment in the MVM group (p 2 mm linear extent) were significantly associated with chronic or gestational hypertension (OR = 4.10; p 2 mm in size is recommended, as these lesions correlate with other MVM lesions and MVM-predisposing morbidities. Other lesions, particularly DLN and ETI, lacked such association questioning their diagnostic utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States; University of Missouri, Columbia, MO, United States.
- Department of Pathology, Boston Children's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
- Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
- Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: cparra-herran@bwh.harvard.edu.
Zitieren
APA
Lechner, A. C., Slack, J. C., Carreon, C. K., Quade, B. J., & Parra-Herran, C. (2023). Placental lesions attributed to shallow implantation, excess extravillous trophoblast and decidual hypoxia: Correlation with maternal vascular malperfusion and related obstetric conditions. Placenta. https://doi.org/10.1016/j.placenta.2023.05.020
Vancouver
Lechner AC, Slack JC, Carreon CK, Quade BJ, Parra-Herran C. Placental lesions attributed to shallow implantation, excess extravillous trophoblast and decidual hypoxia: Correlation with maternal vascular malperfusion and related obstetric conditions. Placenta. 2023. doi:10.1016/j.placenta.2023.05.020
BibTeX
@article{Lechner2023,
author = {Lechner, Adam C and Slack, Jonathan C and Carreon, Chrystalle Katte and Quade, Bradley J and Parra-Herran, Carlos},
title = {Placental lesions attributed to shallow implantation, excess extravillous trophoblast and decidual hypoxia: Correlation with maternal vascular malperfusion and related obstetric conditions},
journal = {Placenta},
year = {2023},
doi = {10.1016/j.placenta.2023.05.020}
}
EUVIMED